Standardizing biomarker testing for Canadian patients with advanced lung cancer.

MLA

Melosky, B., et al. “Standardizing Biomarker Testing for Canadian Patients with Advanced Lung Cancer.” Current Oncology, vol. 25, no. 1, Feb. 2018, pp. 73–82. EBSCOhost, https://doi.org/10.3747/co.25.3867.

APA

Melosky, B., Blais, N., Cheema, P., Couture, C., Juergens, R., Kamel-Reid, S., Tsao, M.-S., Wheatley-Price, P., Xu, Z., & Ionescu, D. N. (2018). Standardizing biomarker testing for Canadian patients with advanced lung cancer. Current Oncology, 25(1), 73–82. https://doi.org/10.3747/co.25.3867

Chicago

Melosky, B., N. Blais, P. Cheema, C. Couture, R. Juergens, S. Kamel-Reid, M.-S. Tsao, P. Wheatley-Price, Z. Xu, and D. N. Ionescu. 2018. “Standardizing Biomarker Testing for Canadian Patients with Advanced Lung Cancer.” Current Oncology 25 (1): 73–82. doi:10.3747/co.25.3867.